Exelixis Inc
(EXEL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXEL | RGC | BMRN | ||
| Company | Exelixis Inc | Regencell Bioscience Holdings Ltd | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 43.46 | 27.00 | 59.43 | ||
| High | 43.83 | 27.21 | 60.79 | ||
| Low | 40.92 | 25.80 | 58.62 | ||
| Latest | 42.94 | 26.72 | 60.31 | ||
| Change | -0.04 | +0.04 | +0.65 | ||
| % Change | -0.09% | +0.15% | +1.09% | ||
| Volume | 3,954,200 | 56,300 | 2,646,600 | ||
| 20-Day Average Volume | 2,611,920 | 382,560 | 2,036,345 | ||
| Previous Close | 42.98 | 26.68 | 59.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 43.49 | 28.30 | 57.11 | ||
| 20-Day Raw Stochastic | 45.89% | 34.40% | 92.86% | ||
| 20-Day Relative Strength | 48.52 | 49.99 | 59.97 | ||
| Weighted Alpha | +15.18 | +89.20 | -2.04 | ||
| Today's Opinion | 40% Buy | 80% Buy | 88% Buy | ||
| Previous Opinion | 40% Buy | 80% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.68% since 02/04/26 | -5.85% since 02/04/26 | +4.67% since 02/04/26 | ||
| Low | 40.92 on 02/11/26 | 24.62 on 02/05/26 | 56.87 on 02/05/26 | ||
| High | 44.28 on 02/10/26 | 29.00 on 02/05/26 | 60.79 on 02/11/26 | ||
| 1-Month | |||||
| %Chg | -2.50% since 01/09/26 | -41.65% since 01/09/26 | +2.31% since 01/09/26 | ||
| Low | 40.54 on 02/02/26 | 20.81 on 01/22/26 | 54.06 on 01/20/26 | ||
| High | 45.77 on 01/15/26 | 50.22 on 01/12/26 | 60.79 on 02/11/26 | ||
| 3-Month | |||||
| %Chg | -0.08% since 11/11/25 | +83.77% since 11/11/25 | +9.79% since 11/11/25 | ||
| Low | 40.54 on 02/02/26 | 10.33 on 11/25/25 | 50.90 on 12/15/25 | ||
| High | 47.24 on 12/23/25 | 69.00 on 01/08/26 | 63.89 on 12/19/25 | ||
| 6-Month | |||||
| %Chg | +14.78% since 08/11/25 | +97.63% since 08/11/25 | +6.18% since 08/11/25 | ||
| Low | 33.76 on 10/20/25 | 10.33 on 11/25/25 | 50.76 on 11/07/25 | ||
| High | 47.24 on 12/23/25 | 69.00 on 01/08/26 | 63.89 on 12/19/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,523,454 | 13,192,968 | 11,461,520 | ||
| Shares Outstanding, K | 268,112 | 494,489 | 192,114 | ||
| Annual Sales | 2,168,700,000 | 0 | 2,853,920,000 | ||
| Annual Net Income | 521,270,000 | -3,580,000 | 426,860,000 | ||
| Last Quarter Sales | 597,760,000 | N/A | 776,130,000 | ||
| Last Quarter Net Income | 193,580,000 | N/A | -30,740,000 | ||
| 60-Month Beta | 0.42 | 2.02 | 0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.94 on 02/10/26 | N/A | 0.12 on 10/27/25 | ||
| Latest Earnings Date | 02/10/26 | 01/30/26 | 02/18/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 02/15/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.86 | 0.00 | 20.14 | ||